Table 2.
Group | SOD (U/mg prot) | MDA (nmol/mg prot) | CAT (U/mg prot) | GSH-Px (nmol/mg prot) |
---|---|---|---|---|
Control | 114.86 ± 6.54b | 5.11 ± 0.64b | 18.27 ± 1.18b | 477.24 ± 21.61b |
Model | 66.38 ± 6.53 | 10.12 ± 1.65 | 9.04 ± 1.52 | 355.72 ± 23.95 |
Low dose | 75.24 ± 9.38bA## | 9.08 ± 0.58bA## | 11.28 ± 0.97bB## | 373.10 ± 17.40B## |
Medium dose | 86.69 ± 7.02bA## | 7.77 ± 0.80bB## | 13.03 ± 0.80bA## | 397.39 ± 15.74bB## |
High dose | 100.44 ± 10.42b## | 6.08 ± 0.44b# | 14.92 ± 0.79b## | 435.38 ± 19.28b## |
Vitamin E | 96.15 ± 6.47b## | 6.26 ± 0.63b## | 14.37 ± 1.32b## | 430.48 ± 5.64b## |
Values are the mean ± SD.
b P < 0.01 compared with model group (all groups).
A P < 0.05; B P < 0.01 compared with Vit E group (IBFTF groups).
# P < 0.05; ## P < 0.01 compared with control group (Vit E and IBFTF groups).